Background Only clinically validated HPV assays can be accepted in cervical cancer
screening. Objectives To update the list of high-risk HPV assays that fulfil the 2009 …

Background Cytology-based screening has been a cornerstone of cervical cancer
prevention for decades. Following extensive evidence demonstrating higher sensitivity and …

Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Background Screening for human papillomavirus (HPV) infection is more effective in
reducing the incidence of cervical cancer than screening using Pap smears. Moreover, HPV …

An update to the American Cancer Society (ACS) guideline regarding screening for the early
detection of cervical precancerous lesions and cancer is presented. The guidelines are …

More than ever, clinicians need regularly updated reviews given the continuously increasing
amount of new information regarding innovative cervical cancer prevention methods. A …

Head and neck squamous cell carcinomas (HNSCCs) are caused by tobacco and alcohol
consumption and by infection with high-risk types of human papillomavirus (HPV). Tumours …

Cytology-based cervical screening had unequivocal success in reducing the incidence and
mortality of cervical cancer in the last century. The recognition of the role of human …

Background Cervical cancer screening tests that identify DNA of the main causal agent, high-
risk human papillomavirus (HPV) types, are more protective than cervical cytology. We …